These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hypoglycemia in patients treated with linezolid. Viswanathan P; Iarikov D; Wassel R; Davidson A; Nambiar S Clin Infect Dis; 2014 Oct; 59(8):e93-5. PubMed ID: 24965346 [TBL] [Abstract][Full Text] [Related]
5. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia. Tavil B; Balci YI; Yildirim I; Tavil Y; Secmeer G; Ceyhan M; Tuncer M Pediatr Hematol Oncol; 2008; 25(1):67-71. PubMed ID: 18231956 [TBL] [Abstract][Full Text] [Related]
6. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events. Thai XC; Bruno-Murtha LA Pharmacotherapy; 2006 Aug; 26(8):1183-9. PubMed ID: 16863496 [TBL] [Abstract][Full Text] [Related]
7. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus. Sobieraj DM; Freyer CW Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361 [TBL] [Abstract][Full Text] [Related]
8. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. McKinnon PS; Sorensen SV; Liu LZ; Itani KM Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis. Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775 [TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Sharpe JN; Shively EH; Polk HC Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Bounthavong M; Hsu DI Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of linezolid in liver transplant patients. Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969 [TBL] [Abstract][Full Text] [Related]
15. Severe hypoglycemia from clarithromycin-repaglinide drug interaction. Khamaisi M; Leitersdorf E Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665 [TBL] [Abstract][Full Text] [Related]
16. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720 [TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Jauregui LE; Babazadeh S; Seltzer E; Goldberg L; Krievins D; Frederick M; Krause D; Satilovs I; Endzinas Z; Breaux J; O'Riordan W Clin Infect Dis; 2005 Nov; 41(10):1407-15. PubMed ID: 16231250 [TBL] [Abstract][Full Text] [Related]
18. Elevated creatine phosphokinase levels associated with linezolid therapy. Allison GW; Perla RJ; Belliveau PP; Angelis SM Am J Health Syst Pharm; 2009 Jun; 66(12):1097-100. PubMed ID: 19498124 [TBL] [Abstract][Full Text] [Related]
19. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]